BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maxan A, Sciacca G, Alpaugh M, Tao Z, Breger L, Dehay B, Ling Z, Chuan Q, Cisbani G, Masnata M, Salem S, Lacroix S, Oueslati A, Bezard E, Cicchetti F. Use of adeno-associated virus-mediated delivery of mutant huntingtin to study the spreading capacity of the protein in mice and non-human primates. Neurobiol Dis 2020;141:104951. [PMID: 32439599 DOI: 10.1016/j.nbd.2020.104951] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Weiss AR, Liguore WA, Brandon K, Wang X, Liu Z, Domire JS, Button D, Srinivasan S, Kroenke CD, McBride JL. A novel rhesus macaque model of Huntington's disease recapitulates key neuropathological changes along with motor and cognitive decline. Elife 2022;11:e77568. [PMID: 36205397 DOI: 10.7554/eLife.77568] [Reference Citation Analysis]
2 Comoy EE, Mikol J, Deslys J. Non-human primates in prion diseases. Cell Tissue Res. [DOI: 10.1007/s00441-022-03644-7] [Reference Citation Analysis]
3 Lunev E, Karan A, Egorova T, Bardina M. Adeno-Associated Viruses for Modeling Neurological Diseases in Animals: Achievements and Prospects. Biomedicines 2022;10:1140. [DOI: 10.3390/biomedicines10051140] [Reference Citation Analysis]
4 Yan Y, Zhang G, Wu C, Ren Q, Liu X, Huang F, Cao Y, Ye W. Structural Exploration of Polycationic Nanoparticles for siRNA Delivery. ACS Biomater Sci Eng 2022;8:1964-74. [PMID: 35380797 DOI: 10.1021/acsbiomaterials.2c00196] [Reference Citation Analysis]
5 Jansen-west K, Todd TW, Daughrity LM, Yue M, Tong J, Carlomagno Y, Del Rosso G, Kurti A, Jones CY, Dunmore JA, Castanedes-casey M, Dickson DW, Wszolek ZK, Fryer JD, Petrucelli L, Prudencio M. Plasma PolyQ-ATXN3 Levels Associate With Cerebellar Degeneration and Behavioral Abnormalities in a New AAV-Based SCA3 Mouse Model. Front Cell Dev Biol 2022;10:863089. [DOI: 10.3389/fcell.2022.863089] [Reference Citation Analysis]
6 Alpaugh M, Denis HL, Cicchetti F. Prion-like properties of the mutant huntingtin protein in living organisms: the evidence and the relevance. Mol Psychiatry 2021. [PMID: 34711942 DOI: 10.1038/s41380-021-01350-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ramírez-jarquín UN, Sharma M, Shahani N, Li Y, Boregowda S, Subramaniam S. Rhes protein transits from neuron to neuron and facilitates mutant huntingtin spreading in the brain.. [DOI: 10.1101/2021.08.27.457956] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Margarita DC, Colombo L, Urszulax B, Amandine G, Natalia TE, Isabelle F, Hossain I, Daniela G, Anne E, Matthias M, Eline P. Transmission-selective muscle pathology induced by active propagation of mutant huntingtin across the human neuromuscular synapse.. [DOI: 10.1101/2021.07.28.454044] [Reference Citation Analysis]
9 Schindler F, Praedel N, Neuendorf N, Kunz S, Schnoegl S, Mason MA, Taxy BA, Bates GP, Khoshnan A, Priller J, Grimm J, Maier M, Boeddrich A, Wanker EE. Small, Seeding-Competent Huntingtin Fibrils Are Prominent Aggregate Species in Brains of zQ175 Huntington's Disease Knock-in Mice. Front Neurosci 2021;15:682172. [PMID: 34239412 DOI: 10.3389/fnins.2021.682172] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Masnata M, Salem S, de Rus Jacquet A, Anwer M, Cicchetti F. Targeting Tau to Treat Clinical Features of Huntington's Disease. Front Neurol 2020;11:580732. [PMID: 33329322 DOI: 10.3389/fneur.2020.580732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]